Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to David B Badesch

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Badesch, David

Item TypeName
Academic Article Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
Academic Article Independent ventilation and ECMO for severe unilateral pulmonary edema after SLT for primary pulmonary hypertension.
Academic Article A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
Academic Article Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link?
Academic Article Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension.
Academic Article Clinical trials in pulmonary hypertension.
Academic Article Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Academic Article Bosentan therapy for pulmonary arterial hypertension.
Academic Article Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
Academic Article Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
Academic Article Pulmonary hypertension associated with connective tissue disease.
Academic Article Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection.
Academic Article The pressure-overloaded right ventricle in pulmonary hypertension.
Academic Article Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.
Academic Article Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
Academic Article Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension.
Academic Article Pulmonary vascular manifestations of mixed connective tissue disease.
Academic Article Survival with first-line bosentan in patients with primary pulmonary hypertension.
Academic Article Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy.
Academic Article Autoimmunity and pulmonary hypertension: a perspective.
Academic Article Ambrisentan therapy for pulmonary arterial hypertension.
Academic Article Evaluation and management of the patient with pulmonary arterial hypertension.
Academic Article Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Academic Article Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress.
Academic Article Temporal trends and drug exposures in pulmonary hypertension: an American experience.
Academic Article Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.
Academic Article Clinical risk factors for portopulmonary hypertension.
Academic Article Surrogate and combined end points in pulmonary arterial hypertension.
Academic Article Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
Academic Article Serotonin transporter polymorphisms in patients with portopulmonary hypertension.
Academic Article Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.
Academic Article ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
Academic Article Pulmonary function testing in patients with pulmonary arterial hypertension.
Academic Article Diagnosis and assessment of pulmonary arterial hypertension.
Academic Article Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
Academic Article Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
Academic Article Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns.
Academic Article Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.
Academic Article Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Academic Article Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension.
Academic Article Hyperuricemia in severe pulmonary hypertension.
Academic Article Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey.
Academic Article ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Academic Article Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
Academic Article Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
Academic Article An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Academic Article Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Academic Article The study of risk in pulmonary arterial hypertension.
Academic Article Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.
Academic Article Beraprost therapy for pulmonary arterial hypertension.
Academic Article Importance of angiotensin-converting enzyme in pulmonary hypertension.
Academic Article Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8.
Academic Article Prostanoid therapy for pulmonary arterial hypertension.
Academic Article Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
Academic Article Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension.
Academic Article Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.
Academic Article Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
Academic Article Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
Academic Article Insulin-like growth factor I and pulmonary hypertension induced by continuous air embolization in sheep.
Academic Article Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
Academic Article Sildenafil citrate therapy for pulmonary arterial hypertension.
Academic Article Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
Academic Article Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.
Academic Article Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
Academic Article Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
Academic Article Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Academic Article Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
Academic Article Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Academic Article ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
Academic Article Role of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.
Academic Article End points and clinical trial design in pulmonary arterial hypertension.
Academic Article Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.
Academic Article The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Academic Article Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.
Academic Article Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Academic Article The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
Academic Article Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Concept Hypertension, Pulmonary
Concept Hypertension, Portal
Academic Article Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
Academic Article Definitions and diagnosis of pulmonary hypertension.
Academic Article Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
Academic Article An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
Academic Article Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.
Academic Article Timed response to inhaled nitric oxide in pulmonary hypertension.
Academic Article Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
Academic Article Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
Academic Article Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.
Academic Article Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Academic Article [Definitions and diagnosis of pulmonary hypertension].
Academic Article Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
Academic Article Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Academic Article Validation of two predictive models for survival in pulmonary arterial hypertension.
Academic Article Five-Year outcomes of patients enrolled in the REVEAL Registry.
Academic Article Management of pulmonary hypertension.
Academic Article Anticoagulation in Pulmonary Arterial Hypertension.
Academic Article Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
Academic Article Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
Academic Article Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.
Grant RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION
Grant HYPERTENSIVE PULMONARY VASCULAR REMODELING--ROLE OF IGF
Academic Article Update on pulmonary arterial hypertension research: proceedings from a meeting of experts.
Academic Article Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
Academic Article Exercise-Induced Pulmonary Hypertension: Translating Pathophysiological Concepts Into Clinical Practice.
Academic Article Overdue to understand anticoagulation in pulmonary arterial hypertension.
Academic Article Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL.
Academic Article Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
Academic Article Response.
Academic Article Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.
Academic Article Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.
Academic Article Diagnosis of pulmonary hypertension.
Academic Article Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report.
Concept Familial Primary Pulmonary Hypertension
Academic Article United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications.
Academic Article Response.
Academic Article Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case-control study.
Academic Article Pulmonary Arterial Hypertension-Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting.
Academic Article United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics.
Academic Article Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Academic Article Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Academic Article Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry.
Academic Article EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
Academic Article Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR).
Academic Article Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
Academic Article Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
Academic Article Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer.
Academic Article Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.

Search Criteria
  • Hypertension

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)